Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00132054
Status:
COMPLETED
Last Update Posted:
2013-05-30
First Post:
2005-08-16
Brief Title:
Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer
Sponsor:
Japan Multinational Trial Organization
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
JMTO-LC03-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Japan Multinational Trial Organization
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None